ArticleFrontiers in pharmacology2021

Single Dose of SHR-1222, a Sclerostin Monoclonal Antibody, in Healthy Men and Postmenopausal Women With Low Bone Mass: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation, Phase I Study.

Zhijie Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.